Correlation of multidrug-resistance gene (MDR1) expression levels and outcome to adjuvant cisplatin/MTX based chemotherapy in patients enrolled in the AUO-AB 05/95 phase III trialA. C. Hoffman, Anders Hartmann, Simone Bertz et al.|Journal of Clinical Oncology|2009Cited by 1
Use of multidrug-resistance gene (MDR1) expression levels to predict outcome to adjuvant cisplatin/gemcitabine based chemotherapy in patients with with locally advanced urothelial cancerThomas Gauler, A. Hartmann, A. C. Hoffman et al.|Journal of Clinical Oncology|2009Cited by 0